APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coccidioidomycosis Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Coccidioidomycosis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchCoccidioidomycosis Drug Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Coccidioidomycosis Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Coccidioidomycosis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coccidioidomycosis Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Coccidioidomycosis Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Coccidioidomycosis Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Coccidioidomycosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Coccidioidomycosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coccidioidomycosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Coccidioidomycosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Coccidioidomycosis Drug include Yi Kang Pharm, Teva Pharmaceuticals, ShiJiaZhuang No.4 Pharmaceutical, Qilu Pharmaceutical Group, Minsheng Pharmaceutical, Mylan, Lunan Pharmaceutical, Kelun and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Coccidioidomycosis Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Coccidioidomycosis Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Coccidioidomycosis Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Coccidioidomycosis Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Coccidioidomycosis Drug Segment by Company

Yi Kang Pharm

Teva Pharmaceuticals

ShiJiaZhuang No.4 Pharmaceutical

Qilu Pharmaceutical Group

Minsheng Pharmaceutical

Mylan

Lunan Pharmaceutical

Kelun

Pfizer

Bayer

Baxter

Sanofi-Aventis

Hexal

Apotex

Coccidioidomycosis Drug Segment by Type

Voriconazole

Fluconazole

Amphotericin B

Posaconazole

Others

Coccidioidomycosis Drug Segment by Application

Hospital

Retail

Others

Coccidioidomycosis Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coccidioidomycosis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coccidioidomycosis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coccidioidomycosis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Coccidioidomycosis Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Coccidioidomycosis Drug industry.

Chapter 3: Detailed analysis of Coccidioidomycosis Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Coccidioidomycosis Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Coccidioidomycosis Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Voriconazole Table 3. Key Players of Fluconazole Table 4. Key Players of Amphotericin B Table 3. Key Players of Posaconazole Table 4. Key Players of Others Table 5. Global Coccidioidomycosis Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospital Table 7. Key Players of Retail Table 8. Key Players of Others Table 9. Global Coccidioidomycosis Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Coccidioidomycosis Drug Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Coccidioidomycosis Drug Market Share by Region (2021-2026) Table 12. Global Coccidioidomycosis Drug Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Coccidioidomycosis Drug Market Share by Region (2027-2032) Table 14. Coccidioidomycosis Drug Industry Trends Table 15. Coccidioidomycosis Drug Industry Drivers Table 16. Coccidioidomycosis Drug Industry Opportunities and Challenges Table 17. Coccidioidomycosis Drug Industry Restraints Table 18. Global Coccidioidomycosis Drug Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Coccidioidomycosis Drug Revenue Market Share by Company (2021-2026) Table 20. Global Coccidioidomycosis Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Coccidioidomycosis Drug Key Company Head Office and Area Served Table 22. Global Coccidioidomycosis Drug Company, Product Type & Application Table 23. Global Coccidioidomycosis Drug Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Coccidioidomycosis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Coccidioidomycosis Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Coccidioidomycosis Drug Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Coccidioidomycosis Drug Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Coccidioidomycosis Drug Revenue Market Share by Type (2021-2026) Table 30. Global Coccidioidomycosis Drug Revenue Market Share by Type (2027-2032) Table 31. Global Coccidioidomycosis Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Coccidioidomycosis Drug Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Coccidioidomycosis Drug Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Coccidioidomycosis Drug Revenue Market Share by Application (2021-2026) Table 35. Global Coccidioidomycosis Drug Revenue Market Share by Application (2027-2032) Table 36. Yi Kang Pharm Company Information Table 37. Yi Kang Pharm Business Overview Table 38. Yi Kang Pharm Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Yi Kang Pharm Coccidioidomycosis Drug Product Portfolio Table 40. Yi Kang Pharm Recent Development Table 41. Teva Pharmaceuticals Company Information Table 42. Teva Pharmaceuticals Business Overview Table 43. Teva Pharmaceuticals Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Teva Pharmaceuticals Coccidioidomycosis Drug Product Portfolio Table 45. Teva Pharmaceuticals Recent Development Table 46. ShiJiaZhuang No.4 Pharmaceutical Company Information Table 47. ShiJiaZhuang No.4 Pharmaceutical Business Overview Table 48. ShiJiaZhuang No.4 Pharmaceutical Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. ShiJiaZhuang No.4 Pharmaceutical Coccidioidomycosis Drug Product Portfolio Table 50. ShiJiaZhuang No.4 Pharmaceutical Recent Development Table 51. Qilu Pharmaceutical Group Company Information Table 52. Qilu Pharmaceutical Group Business Overview Table 53. Qilu Pharmaceutical Group Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Qilu Pharmaceutical Group Coccidioidomycosis Drug Product Portfolio Table 55. Qilu Pharmaceutical Group Recent Development Table 56. Minsheng Pharmaceutical Company Information Table 57. Minsheng Pharmaceutical Business Overview Table 58. Minsheng Pharmaceutical Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Minsheng Pharmaceutical Coccidioidomycosis Drug Product Portfolio Table 60. Minsheng Pharmaceutical Recent Development Table 61. Mylan Company Information Table 62. Mylan Business Overview Table 63. Mylan Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Mylan Coccidioidomycosis Drug Product Portfolio Table 65. Mylan Recent Development Table 66. Lunan Pharmaceutical Company Information Table 67. Lunan Pharmaceutical Business Overview Table 68. Lunan Pharmaceutical Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Lunan Pharmaceutical Coccidioidomycosis Drug Product Portfolio Table 70. Lunan Pharmaceutical Recent Development Table 71. Kelun Company Information Table 72. Kelun Business Overview Table 73. Kelun Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Kelun Coccidioidomycosis Drug Product Portfolio Table 75. Kelun Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Pfizer Coccidioidomycosis Drug Product Portfolio Table 80. Pfizer Recent Development Table 81. Bayer Company Information Table 82. Bayer Business Overview Table 83. Bayer Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Bayer Coccidioidomycosis Drug Product Portfolio Table 85. Bayer Recent Development Table 86. Baxter Company Information Table 87. Baxter Business Overview Table 88. Baxter Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Baxter Coccidioidomycosis Drug Product Portfolio Table 90. Baxter Recent Development Table 91. Sanofi-Aventis Company Information Table 92. Sanofi-Aventis Business Overview Table 93. Sanofi-Aventis Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Sanofi-Aventis Coccidioidomycosis Drug Product Portfolio Table 95. Sanofi-Aventis Recent Development Table 96. Hexal Company Information Table 97. Hexal Business Overview Table 98. Hexal Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Hexal Coccidioidomycosis Drug Product Portfolio Table 100. Hexal Recent Development Table 101. Apotex Company Information Table 102. Apotex Business Overview Table 103. Apotex Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Apotex Coccidioidomycosis Drug Product Portfolio Table 105. Apotex Recent Development Table 106. North America Coccidioidomycosis Drug Market Size by Type (2021-2026) & (US$ Million) Table 107. North America Coccidioidomycosis Drug Market Size by Type (2027-2032) & (US$ Million) Table 108. North America Coccidioidomycosis Drug Market Size by Application (2021-2026) & (US$ Million) Table 109. North America Coccidioidomycosis Drug Market Size by Application (2027-2032) & (US$ Million) Table 110. North America Coccidioidomycosis Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Coccidioidomycosis Drug Market Size by Country (2021-2026) Table 112. North America Coccidioidomycosis Drug Market Size by Country (2027-2032) Table 113. Europe Coccidioidomycosis Drug Market Size by Type (2021-2026) & (US$ Million) Table 114. Europe Coccidioidomycosis Drug Market Size by Type (2027-2032) & (US$ Million) Table 115. Europe Coccidioidomycosis Drug Market Size by Application (2021-2026) & (US$ Million) Table 116. Europe Coccidioidomycosis Drug Market Size by Application (2027-2032) & (US$ Million) Table 117. Europe Coccidioidomycosis Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Coccidioidomycosis Drug Market Size by Country (2021-2026) Table 119. Europe Coccidioidomycosis Drug Market Size by Country (2027-2032) Table 120. China Coccidioidomycosis Drug Market Size by Type (2021-2026) & (US$ Million) Table 121. China Coccidioidomycosis Drug Market Size by Type (2027-2032) & (US$ Million) Table 122. China Coccidioidomycosis Drug Market Size by Application (2021-2026) & (US$ Million) Table 123. China Coccidioidomycosis Drug Market Size by Application (2027-2032) & (US$ Million) Table 124. Asia Coccidioidomycosis Drug Market Size by Type (2021-2026) & (US$ Million) Table 125. Asia Coccidioidomycosis Drug Market Size by Type (2027-2032) & (US$ Million) Table 126. Asia Coccidioidomycosis Drug Market Size by Application (2021-2026) & (US$ Million) Table 127. Asia Coccidioidomycosis Drug Market Size by Application (2027-2032) & (US$ Million) Table 128. Asia Coccidioidomycosis Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Asia Coccidioidomycosis Drug Market Size by Country (2021-2026) Table 130. Asia Coccidioidomycosis Drug Market Size by Country (2027-2032) Table 131. South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Type (2021-2026) & (US$ Million) Table 132. South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Type (2027-2032) & (US$ Million) Table 133. South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Application (2021-2026) & (US$ Million) Table 134. South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Application (2027-2032) & (US$ Million) Table 135. South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Country (2021-2026) Table 137. South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Coccidioidomycosis Drug Product Image Figure 2. Global Coccidioidomycosis Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Coccidioidomycosis Drug Market Share by Type: 2025 VS 2032 Figure 4. Voriconazole Image Figure 5. Fluconazole Image Figure 6. Amphotericin B Image Figure 7. Posaconazole Image Figure 8. Others Image Figure 9. Global Coccidioidomycosis Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Coccidioidomycosis Drug Market Share by Application: 2025 VS 2032 Figure 11. Hospital Image Figure 12. Retail Image Figure 13. Others Image Figure 14. Global Coccidioidomycosis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 16. Global Coccidioidomycosis Drug Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Coccidioidomycosis Drug Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Coccidioidomycosis Drug Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Coccidioidomycosis Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Coccidioidomycosis Drug Revenue Market Share by Type (2021-2032) Figure 23. Global Coccidioidomycosis Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Coccidioidomycosis Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 26. North America Coccidioidomycosis Drug Market Share by Type (2021-2032) Figure 27. North America Coccidioidomycosis Drug Market Share by Application (2021-2032) Figure 28. North America Coccidioidomycosis Drug Market Share by Country (2021-2032) Figure 29. United States Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 30. Canada Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 32. Europe Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 33. Europe Coccidioidomycosis Drug Market Share by Type (2021-2032) Figure 34. Europe Coccidioidomycosis Drug Market Share by Application (2021-2032) Figure 35. Europe Coccidioidomycosis Drug Market Share by Country (2021-2032) Figure 36. Germany Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 37. France Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 39. Italy Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 40. Russia Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 42. China Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 43. China Coccidioidomycosis Drug Market Share by Type (2021-2032) Figure 44. China Coccidioidomycosis Drug Market Share by Application (2021-2032) Figure 45. Asia Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 46. Asia Coccidioidomycosis Drug Market Share by Type (2021-2032) Figure 47. Asia Coccidioidomycosis Drug Market Share by Application (2021-2032) Figure 48. Asia Coccidioidomycosis Drug Market Share by Country (2021-2032) Figure 49. Japan Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 53. India Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 54. Australia Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Coccidioidomycosis Drug Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Coccidioidomycosis Drug Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Coccidioidomycosis Drug Market Share by Country (2021-2032) Figure 59. Brazil Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 64. UAE Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 66. Chile Coccidioidomycosis Drug Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Voriconazole
  • Fluconazole
  • Amphotericin B
  • Posaconazole
  • Others
Applications
  • Hospital
  • Retail
  • Others
Companies covered
  • Yi Kang Pharm
  • Teva Pharmaceuticals
  • ShiJiaZhuang No.4 Pharmaceutical
  • Qilu Pharmaceutical Group
  • Minsheng Pharmaceutical
  • Mylan
  • Lunan Pharmaceutical
  • Kelun
  • Pfizer
  • Bayer
  • Baxter
  • Sanofi-Aventis
  • Hexal
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Coccidioidomycosis Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Voriconazole
  5. 1.2.3 Fluconazole
  6. 1.2.4 Amphotericin B
  7. 1.2.5 Posaconazole
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Coccidioidomycosis Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Retail
  13. 1.3.4 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Coccidioidomycosis Drug Growth Trends by Region
  16. 1.5.1 Global Coccidioidomycosis Drug Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Coccidioidomycosis Drug Market Size by Region (2021-2026)
  18. 1.5.3 Coccidioidomycosis Drug Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Coccidioidomycosis Drug Market Dynamics
  1. 2.1 Coccidioidomycosis Drug Industry Trends
  2. 2.2 Coccidioidomycosis Drug Industry Drivers
  3. 2.3 Coccidioidomycosis Drug Industry Opportunities and Challenges
  4. 2.4 Coccidioidomycosis Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Coccidioidomycosis Drug Revenue by Company (2021-2026)
  2. 3.2 Global Coccidioidomycosis Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Coccidioidomycosis Drug Key Company Head office and Area Served
  4. 3.4 Global Coccidioidomycosis Drug Company, Product Type & Application
  5. 3.5 Global Coccidioidomycosis Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Coccidioidomycosis Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Coccidioidomycosis Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Coccidioidomycosis Drug Tier 1, Tier 2, and Tier 3
4 Coccidioidomycosis Drug Market by Type
  1. 4.1 Global Coccidioidomycosis Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Coccidioidomycosis Drug Market Size by Type (2021-2032)
  3. 4.3 Global Coccidioidomycosis Drug Market Size Share by Type (2021-2032)
5 Coccidioidomycosis Drug Market by Application
  1. 5.1 Global Coccidioidomycosis Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Coccidioidomycosis Drug Market Size by Application (2021-2032)
  3. 5.3 Global Coccidioidomycosis Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Yi Kang Pharm
  2. 6.1.1 Yi Kang Pharm Company Information
  3. 6.1.2 Yi Kang Pharm Business Overview
  4. 6.1.3 Yi Kang Pharm Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Yi Kang Pharm Coccidioidomycosis Drug Product Portfolio
  6. 6.1.5 Yi Kang Pharm Recent Developments
  7. 6.2 Teva Pharmaceuticals
  8. 6.2.1 Teva Pharmaceuticals Company Information
  9. 6.2.2 Teva Pharmaceuticals Business Overview
  10. 6.2.3 Teva Pharmaceuticals Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Teva Pharmaceuticals Coccidioidomycosis Drug Product Portfolio
  12. 6.2.5 Teva Pharmaceuticals Recent Developments
  13. 6.3 ShiJiaZhuang No.4 Pharmaceutical
  14. 6.3.1 ShiJiaZhuang No.4 Pharmaceutical Company Information
  15. 6.3.2 ShiJiaZhuang No.4 Pharmaceutical Business Overview
  16. 6.3.3 ShiJiaZhuang No.4 Pharmaceutical Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 ShiJiaZhuang No.4 Pharmaceutical Coccidioidomycosis Drug Product Portfolio
  18. 6.3.5 ShiJiaZhuang No.4 Pharmaceutical Recent Developments
  19. 6.4 Qilu Pharmaceutical Group
  20. 6.4.1 Qilu Pharmaceutical Group Company Information
  21. 6.4.2 Qilu Pharmaceutical Group Business Overview
  22. 6.4.3 Qilu Pharmaceutical Group Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Qilu Pharmaceutical Group Coccidioidomycosis Drug Product Portfolio
  24. 6.4.5 Qilu Pharmaceutical Group Recent Developments
  25. 6.5 Minsheng Pharmaceutical
  26. 6.5.1 Minsheng Pharmaceutical Company Information
  27. 6.5.2 Minsheng Pharmaceutical Business Overview
  28. 6.5.3 Minsheng Pharmaceutical Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Minsheng Pharmaceutical Coccidioidomycosis Drug Product Portfolio
  30. 6.5.5 Minsheng Pharmaceutical Recent Developments
  31. 6.6 Mylan
  32. 6.6.1 Mylan Company Information
  33. 6.6.2 Mylan Business Overview
  34. 6.6.3 Mylan Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Mylan Coccidioidomycosis Drug Product Portfolio
  36. 6.6.5 Mylan Recent Developments
  37. 6.7 Lunan Pharmaceutical
  38. 6.7.1 Lunan Pharmaceutical Company Information
  39. 6.7.2 Lunan Pharmaceutical Business Overview
  40. 6.7.3 Lunan Pharmaceutical Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Lunan Pharmaceutical Coccidioidomycosis Drug Product Portfolio
  42. 6.7.5 Lunan Pharmaceutical Recent Developments
  43. 6.8 Kelun
  44. 6.8.1 Kelun Company Information
  45. 6.8.2 Kelun Business Overview
  46. 6.8.3 Kelun Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Kelun Coccidioidomycosis Drug Product Portfolio
  48. 6.8.5 Kelun Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Pfizer Coccidioidomycosis Drug Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Bayer
  56. 6.10.1 Bayer Company Information
  57. 6.10.2 Bayer Business Overview
  58. 6.10.3 Bayer Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Bayer Coccidioidomycosis Drug Product Portfolio
  60. 6.10.5 Bayer Recent Developments
  61. 6.11 Baxter
  62. 6.11.1 Baxter Company Information
  63. 6.11.2 Baxter Business Overview
  64. 6.11.3 Baxter Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Baxter Coccidioidomycosis Drug Product Portfolio
  66. 6.11.5 Baxter Recent Developments
  67. 6.12 Sanofi-Aventis
  68. 6.12.1 Sanofi-Aventis Company Information
  69. 6.12.2 Sanofi-Aventis Business Overview
  70. 6.12.3 Sanofi-Aventis Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Sanofi-Aventis Coccidioidomycosis Drug Product Portfolio
  72. 6.12.5 Sanofi-Aventis Recent Developments
  73. 6.13 Hexal
  74. 6.13.1 Hexal Company Information
  75. 6.13.2 Hexal Business Overview
  76. 6.13.3 Hexal Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Hexal Coccidioidomycosis Drug Product Portfolio
  78. 6.13.5 Hexal Recent Developments
  79. 6.14 Apotex
  80. 6.14.1 Apotex Company Information
  81. 6.14.2 Apotex Business Overview
  82. 6.14.3 Apotex Coccidioidomycosis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Apotex Coccidioidomycosis Drug Product Portfolio
  84. 6.14.5 Apotex Recent Developments
7 North America
  1. 7.1 North America Coccidioidomycosis Drug Market Size (2021-2032)
  2. 7.2 North America Coccidioidomycosis Drug Market Size by Type
  3. 7.2.1 North America Coccidioidomycosis Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Coccidioidomycosis Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Coccidioidomycosis Drug Market Share by Type (2021-2032)
  6. 7.3 North America Coccidioidomycosis Drug Market Size by Application
  7. 7.3.1 North America Coccidioidomycosis Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Coccidioidomycosis Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Coccidioidomycosis Drug Market Share by Application (2021-2032)
  10. 7.4 North America Coccidioidomycosis Drug Market Size by Country
  11. 7.4.1 North America Coccidioidomycosis Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Coccidioidomycosis Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Coccidioidomycosis Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Coccidioidomycosis Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Coccidioidomycosis Drug Market Size (2021-2032)
  2. 8.2 Europe Coccidioidomycosis Drug Market Size by Type
  3. 8.2.1 Europe Coccidioidomycosis Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Coccidioidomycosis Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Coccidioidomycosis Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Coccidioidomycosis Drug Market Size by Application
  7. 8.3.1 Europe Coccidioidomycosis Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Coccidioidomycosis Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Coccidioidomycosis Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Coccidioidomycosis Drug Market Size by Country
  11. 8.4.1 Europe Coccidioidomycosis Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Coccidioidomycosis Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Coccidioidomycosis Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Coccidioidomycosis Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Coccidioidomycosis Drug Market Size (2021-2032)
  2. 9.2 China Coccidioidomycosis Drug Market Size by Type
  3. 9.2.1 China Coccidioidomycosis Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Coccidioidomycosis Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Coccidioidomycosis Drug Market Share by Type (2021-2032)
  6. 9.3 China Coccidioidomycosis Drug Market Size by Application
  7. 9.3.1 China Coccidioidomycosis Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Coccidioidomycosis Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Coccidioidomycosis Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Coccidioidomycosis Drug Market Size (2021-2032)
  2. 10.2 Asia Coccidioidomycosis Drug Market Size by Type
  3. 10.2.1 Asia Coccidioidomycosis Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Coccidioidomycosis Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Coccidioidomycosis Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Coccidioidomycosis Drug Market Size by Application
  7. 10.3.1 Asia Coccidioidomycosis Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Coccidioidomycosis Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Coccidioidomycosis Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Coccidioidomycosis Drug Market Size by Country
  11. 10.4.1 Asia Coccidioidomycosis Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Coccidioidomycosis Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Coccidioidomycosis Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Coccidioidomycosis Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Coccidioidomycosis Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Coccidioidomycosis Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Coccidioidomycosis Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Coccidioidomycosis Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Coccidioidomycosis Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst